• Info
  • Insider Ownership

Insider Trading & Ownership of Sandra Milligan

Location
San Diego, CA
Summary
The estimated net worth of Sandra Milligan is at least $940,049 dollars as of 20 Aug 2025. Sandra Milligan is the Head of Research & Development of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $723,042. Sandra Milligan is the Director of Gossamer Bio, Inc. and owns shares of Gossamer Bio, Inc. (GOSS) stock worth about $111,456. Sandra Milligan is the Interim CEO of Aspira Women's Health Inc. and owns shares of Aspira Women's Health Inc. (AWHL) stock worth about $105,551.
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Sandra Milligan files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Sandra Milligan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OGN Organon & Co. Head of Research & Development $723,042 04 May 2023
GOSS Gossamer Bio, Inc. Director $111,456 +$50,016 +81.4% 19 Aug 2025
AWHL Aspira Women's Health Inc. Interim CEO $105,551 31 Dec 2024
SYRE Spyre Therapeutics, Inc. Director 29 May 2025

Insider Transactions Reported by Sandra Milligan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.